CMPI [NASD]
Checkmate Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.92 Insider Own20.20% Shs Outstand21.63M Perf Week0.38%
Market Cap231.63M Forward P/E- EPS next Y-2.28 Insider Trans-25.50% Shs Float19.66M Perf Month1.06%
Income-63.10M PEG- EPS next Q-0.75 Inst Own77.90% Short Float0.40% Perf Quarter255.94%
Sales- P/S- EPS this Y-42.80% Inst Trans6.45% Short Ratio0.37 Perf Half Y193.30%
Book/sh2.54 P/B4.13 EPS next Y24.50% ROA-75.00% Target Price12.50 Perf Year55.33%
Cash/sh2.72 P/C3.85 EPS next 5Y45.10% ROE-83.90% 52W Range2.00 - 10.50 Perf YTD265.85%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High0.00% Beta-
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin- 52W Low425.00% ATR0.04
Employees30 Current Ratio5.20 Sales Q/Q- Oper. Margin- RSI (14)88.82 Volatility0.23% 0.37%
OptionableNo Debt/Eq0.00 EPS Q/Q-12.10% Profit Margin- Rel Volume0.28 Prev Close10.48
ShortableYes LT Debt/Eq0.00 EarningsMar 29 AMC Payout- Avg Volume216.04K Price10.50
Recom1.70 SMA200.70% SMA5046.89% SMA200129.59% Volume59,987 Change0.19%
May-26-22 05:01PM  
May-12-22 04:30PM  
Apr-20-22 11:16AM  
Apr-19-22 02:58PM  
09:00AM  
08:11AM  
07:00AM  
Apr-08-22 01:01PM  
Mar-29-22 04:30PM  
Mar-08-22 04:30PM  
Feb-10-22 06:14AM  
Feb-09-22 08:00AM  
Jan-31-22 04:30PM  
Jan-11-22 05:36AM  
Jan-03-22 04:30PM  
Dec-20-21 07:00AM  
07:00AM  
Nov-15-21 04:30PM  
Nov-12-21 07:05AM  
07:01AM  
Nov-11-21 04:30PM  
Nov-01-21 08:01AM  
Oct-27-21 04:30PM  
Oct-20-21 04:30PM  
Oct-13-21 07:55AM  
Sep-14-21 04:30PM  
Sep-07-21 07:00AM  
Aug-12-21 04:30PM  
Aug-02-21 04:15PM  
Jul-15-21 02:34AM  
May-20-21 04:30PM  
May-13-21 04:10PM  
May-10-21 06:00AM  
May-04-21 07:00AM  
Apr-28-21 04:30PM  
Apr-19-21 06:00AM  
Apr-16-21 04:27AM  
Apr-12-21 08:36AM  
Apr-11-21 04:01PM  
Apr-09-21 02:16PM  
Mar-29-21 04:30PM  
Mar-10-21 04:30PM  
Jan-04-21 04:30PM  
Dec-20-20 02:14AM  
Dec-08-20 07:00AM  
Dec-01-20 06:30PM  
Nov-13-20 07:00AM  
Nov-09-20 09:00AM  
Nov-07-20 08:58AM  
Nov-03-20 07:00AM  
Oct-15-20 09:20AM  
Sep-23-20 07:00AM  
Sep-18-20 07:00AM  
Sep-09-20 01:00AM  
Aug-06-20 09:17PM  
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naive neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
venBio Global Strategic Fund I10% OwnerMay 16Sale10.4595,8001,001,1002,155,930May 17 05:12 PM
venBio Global Strategic Fund I10% OwnerMay 13Sale10.4535,850374,4642,251,730May 17 05:12 PM
venBio Global Strategic Fund I10% OwnerMay 12Sale10.39124,5251,294,3132,287,580May 12 08:47 PM
venBio Global Strategic Fund I10% OwnerMay 11Sale10.3817,700183,6412,412,105May 12 08:47 PM
venBio Global Strategic Fund I10% OwnerMay 10Sale10.3818,676193,8702,429,805May 12 08:47 PM
venBio Global Strategic Fund I10% OwnerMay 09Sale10.3717,600182,5822,448,481May 09 06:58 PM
venBio Global Strategic Fund I10% OwnerMay 06Sale10.3748,334501,2332,466,081May 09 06:58 PM
venBio Global Strategic Fund I10% OwnerMay 05Sale10.3720,743215,1052,514,415May 09 06:58 PM
venBio Global Strategic Fund I10% OwnerMay 04Sale10.3737,500388,9242,535,158May 04 07:30 PM
venBio Global Strategic Fund I10% OwnerMay 03Sale10.3779,475824,4342,572,658May 04 07:30 PM
venBio Global Strategic Fund I10% OwnerMay 02Sale10.38153,7001,595,9752,652,133May 04 07:30 PM
venBio Global Strategic Fund I10% OwnerApr 29Sale10.3869,230718,6632,805,833Apr 29 05:50 PM
venBio Global Strategic Fund I10% OwnerApr 28Sale10.3873,400761,9362,875,063Apr 29 05:50 PM
venBio Global Strategic Fund I10% OwnerApr 27Sale10.3847,396491,9802,948,463Apr 29 05:50 PM
venBio Global Strategic Fund I10% OwnerApr 26Sale10.3864,683671,5582,995,859Apr 26 06:40 PM
venBio Global Strategic Fund I10% OwnerApr 25Sale10.3927,668287,4043,060,542Apr 26 06:40 PM
venBio Global Strategic Fund I10% OwnerApr 22Sale10.3937,430388,8343,088,210Apr 26 06:40 PM
venBio Global Strategic Fund I10% OwnerApr 21Sale10.3862,200645,8663,125,640Apr 21 08:54 PM
venBio Global Strategic Fund I10% OwnerApr 20Sale10.3985,611889,3873,187,840Apr 21 08:54 PM
venBio Global Strategic Fund I10% OwnerApr 19Sale10.42399,9234,165,2383,273,451Apr 21 08:54 PM
Novo Holdings A/S10% OwnerFeb 25Sale2.703008112,161,990Feb 25 06:21 PM
Novo Holdings A/S10% OwnerFeb 24Sale2.835,99016,9792,162,290Feb 25 06:21 PM
Novo Holdings A/S10% OwnerFeb 23Sale2.901,8205,2772,168,280Feb 25 06:21 PM
Krieg Arthur MChief Scientific OfficerJun 18Buy6.047,22443,633815,734Jun 21 04:26 PM
Krieg Arthur MChief Scientific OfficerJun 16Buy6.183,57822,112808,510Jun 17 04:33 PM